Search
Menu
AdTech Ceramics - Ceramic Packages 1-24 LB

TriLink BioTechnologies Inc.

Facebook X LinkedIn Email
TriLink BioTechnologies Inc. of San Diego has been awarded a Small Business Innovation Research Phase I grant of approximately $100,000. In the Phase I study, the company will investigate its second approach for Hot Start activation of polymerase chain reaction (PCR). This technique, which employs chemically modified triphosphates to inhibit DNA polymerase activity until a thermal activation step, has shown significant promise toward reducing off-target amplification products in PCR.
Trioptics GmbH - Worldwide Benchmark 4-24 LB

Published: July 2007
BiophotonicsDNANews & Featuresthermal activationTriLink BioTechnologies Inc.

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.